Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Accumulated Expenses (2018 - 2019)

Arcturus Therapeutics Holdings' Other Accumulated Expenses history spans 2 years, with the latest figure at $560000.0 for Q3 2019.

  • For Q3 2019, Other Accumulated Expenses changed N/A year-over-year to $560000.0; the TTM value through Sep 2019 reached $560000.0, changed N/A, while the annual FY2018 figure was $674000.0, N/A changed from the prior year.
  • Other Accumulated Expenses reached $560000.0 in Q3 2019 per ARCT's latest filing, down from $1.3 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $1.3 million in Q2 2019 to a low of $560000.0 in Q3 2019.